Kexing Biopharm Attends the Inaugural "Shandong Week in the UK" Exchange and Cooperation Event

Article source：Sep 17,2026View： 7

Recently, Kexing Biopharm traveled to the United Kingdom with the Shandong Provincial delegation to take part in the inaugural "Shandong Week in the UK 2026," hosted by the People's Government of Shandong Province and organized by the Foreign Affairs Office of the Provincial Government. Themed "Trust, Confidence, Future," the event featured a series of exchanges in London, Liverpool, Edinburgh, and other cities, focusing on key areas including trade and commerce, pharmaceuticals, the marine economy, and cultural exchange, to further deepen friendly ties and practical cooperation between Shandong and cities across the UK.

At the opening ceremony of Shandong Week in the UK, held in London together with the Shandong High-Quality Development Comprehensive Promotion Conference, and at the life sciences session of the "Trust and Confidence" Shandong–UK Industry Dialogue, a number of well-known Shandong enterprises gave dedicated presentations, showcasing the province's industrial strength and achievements in high-quality development. During the life sciences session, pharmaceutical, medical device, and cosmetics companies from the province, including Kexing Biopharm, held exchanges and matchmaking meetings with British life sciences institutions and multinational pharmaceutical companies. Guests from both China and the UK spoke highly of the prospects for cooperation between the two sides.

At the event, Kexing Biopharm held in-depth discussions with British guests on topics including innovative drug development, international collaboration in biologics, and overseas market expansion. The Company presented its innovative progress across core pipelines in autoimmune diseases, oncology, and ophthalmology, and conveyed its firm confidence in integrating into the global commercialization network with an open mindset. With the approval and launch of the Company's high-end complex formulation, albumin-bound paclitaxel, in the UK, Kexing Biopharm is moving from "taking products overseas" to "taking its brand overseas."

This high-level dialogue highlighted the depth of Shandong's strength in foreign trade and economic cooperation. As one of the leading representatives of Shandong's pharmaceutical industry, Kexing Biopharm's participation in the delegation is a vivid example of a homegrown enterprise leveraging a provincial-level, high-end platform to accelerate its integration into global markets.

Looking ahead, Kexing Biopharm will continue to embrace global cooperation with an open mindset and strengthen its international competitiveness across R&D, manufacturing, marketing, and other dimensions. The Company is committed to becoming an innovative, internationally oriented biopharmaceutical enterprise, so that high-quality Chinese medicines can benefit more patients.